Iakovlev SV and Ukhin SA |
[Azithromycin: general properties and regimen optimization based on pharmacokinetic and pharmacological parameters]. |
2003 |
Antibiot. Khimioter. |
pmid:12803047
|
Chulig I |
[Pharmacokinetic profile of azithromycin. Role in the treatment of genital Chlamydia infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929112
|
Kuznetsova SM |
["Sumamed in the treatment of urogenital infections"]. |
1996 |
Antibiot. Khimioter. |
pmid:8929115
|
Skripkin IuK et al. |
[The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. |
1996 |
Antibiot. Khimioter. |
pmid:8929120
|
Vasil'ev MM and Gazarian IIu |
[Clinico-laboratory evaluation of the effectiveness of azithromycin in the treatment of patients with Chlamydia and mixed Chlamydia-gonorrhea infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929122
|
Pettus K et al. |
In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25624328
|
Strickman D et al. |
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8585717
|
Feola DJ et al. |
Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20231397
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Marchisio P et al. |
Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124831
|
Jacobsson S et al. |
Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28893785
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Zarantonelli L et al. |
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10508026
|
Caceres SM et al. |
Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25182651
|
Kemp MW et al. |
Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155606
|
Descours G et al. |
Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28069647
|
Engel JN |
Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1280057
|
Kohlhoff SA et al. |
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15105151
|
Brieland JK et al. |
Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10770771
|
Luke DR et al. |
Safety, toleration, and pharmacokinetics of intravenous azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913468
|
Olsen KM et al. |
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913469
|
Hogan PA and Sheehan DJ |
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835536
|
Mukherjee P et al. |
Emergence of high-level azithromycin resistance in Campylobacter jejuni isolates from pediatric diarrhea patients in Kolkata, India. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24777098
|
Achard A et al. |
Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18519724
|
Zasowski E et al. |
Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752270
|
Rouse MS et al. |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257739
|
Yoshioka D et al. |
Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480866
|
Jeong BH et al. |
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480854
|
Noedl H et al. |
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116669
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Roblin PM et al. |
In vitro activity of trovafloxacin against Chlamydia pneumoniae. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303410
|
Frank MO et al. |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336337
|
O'Reilly T et al. |
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336342
|
Seral C et al. |
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821480
|
Bermudez LE and Young LS |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2847644
|
Salman S et al. |
Pharmacokinetics of Transfer of Azithromycin into the Breast Milk of African Mothers. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711756
|
Viscardi RM et al. |
Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23439637
|
Bergman M et al. |
Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16940064
|
Gladue RP et al. |
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2543276
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Araujo FG et al. |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840017
|
Pereira MR et al. |
In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21464242
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Dreses-Werringloer U et al. |
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600348
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Ouadrhiri Y et al. |
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223943
|
Könönen E et al. |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223950
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|